Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Mexiletine and Non Dystrophic Myotonias
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Lamotrigine as Treatment of Myotonia
Characteristics of Nondystrophic Myotonias
Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)
† Study has passed its completion date and status has not been verified in more than two years.